A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated with Huntington's Disease
Administered By
Awarded By
Contributors
- Scott, Burton Lasater Principal Investigator
Start/End
- October 3, 2019 - December 31, 2022